Clinical Assessment of a HYDRAGLYDE ® Regimen
Conditions:  Refractive Errors;  Myopia;  Hypermetropia Interventions:  Device: Lotrafilcon B contact lenses with added wetting agent;  Device: Samfilcon A contact lenses;  Device: POLYQUAD/ALDOX-preserved contact lens solution with added wetting agent;  Device: Hydrogen peroxide-based contact lens solution with added wetting agent;  Device: Senofilcon C contact lenses;  Device: Senofilcon A contact lenses;  Device: Comfilcon A contact lenses;  Device: Habitual Multi-Purpose Solution (HMPS) Sponsor:  Alcon, a Novartis Company Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials